RI
Rajiv Indravadan Modi
About Rajiv Indravadan Modi
Data last updated:
Rajiv Indravadan Modi is a Managing Director at Cadila Pharmaceuticals Limited (since 1991), Director at Irm Energy Limited (since 2015) and Director at Apollo Hospitals International Limited (since 2006), and holds 9 more current directorships. The companies operate in Pharma, Oil & Gas and Healthcare. The 11 current companies with reported revenue have a combined latest revenue of ₹5,694 Cr; the largest is Cadila Pharmaceuticals Limited at ₹3,869 Cr (FY 2025). Earlier, Rajiv Indravadan Modi was a Director at Phd Chamber Of Commerce And Industry (2022–2024) and Director at Cadila Laboratories Private Limited (1991–2024) and 15 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 28 Feb 1991 | 1991 | ₹3,869 Cr (FY 2025) | Active | |
| Director | 01 Dec 2015 | 2015 | ₹980 Cr (FY 2024) | Active | |
| Director | 31 Jul 2006 | 1997 | ₹341 Cr (FY 2025) | Active | |
| Director | 11 Oct 1994 | 1994 | ₹307 Cr (FY 2025) | Active | |
| Director | 04 Aug 2011 | 2009 | ₹152 Cr (FY 2025) | Active | |
| Director | 15 Mar 2016 | 2016 | ₹34.40 Cr (FY 2025) | Active | |
| Director | 24 Mar 2009 | 2009 | ₹8.01 Cr (FY 2025) | Active | |
| Nominee Director | 22 Aug 2019 | 2019 | ₹1.57 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jul 2022 | 1951 | ₹63.29 Cr (FY 2025) | Active | |
| Director | 05 Oct 1991 | 1973 | ₹6.01 Cr (FY 2025) | Active | |
| Director | 13 Jun 2008 | 2008 | ₹15.53 Cr (FY 2023) | Active | |
| Director | 01 Apr 2009 | 2009 | ₹16,816 (FY 2017) | Converted To Llp | |
| Director | 07 Jun 2012 | 2012 | ₹20.1 Lakh (FY 2025) | Active | |
| Director | 01 Oct 2014 | 1973 | ₹4,475 Cr (FY 2026) | Active | |
| Director | 19 Jul 2012 | 2012 | Amalgamated | ||
| Director | 28 Feb 2012 | 2012 | Strike Off | ||
| Director | 07 Jul 2000 | 2000 | Amalgamated | ||
| Director | 26 Mar 1990 | 1981 | ₹6.2 Lakh (FY 2020) | Amalgamated | |
| Director | 24 Mar 1999 | 1994 | Amalgamated | ||
| Director | 17 Oct 1995 | 1995 | ₹1.54 Cr (FY 2020) | Amalgamated | |
| Director | 03 May 1995 | 1995 | Amalgamated | ||
| Director | 15 Apr 1997 | 1997 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajiv Indravadan Modi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Indravadan Modi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Indravadan Modi
Rajiv Indravadan Modi currently holds 12 directorships: Cadila Pharmaceuticals Limited (Managing Director, since 28 Feb 1991, revenue ₹3,869 Cr (FY 2025)); Irm Energy Limited (Director, since 01 Dec 2015, revenue ₹980 Cr (FY 2024)); Apollo Hospitals International Limited (Director, since 31 Jul 2006, revenue ₹341 Cr (FY 2025)); Irm Private Limited (Director, since 11 Oct 1994, revenue ₹307 Cr (FY 2025)); Irm Enterprises Private Limited (Director, since 04 Aug 2011, revenue ₹152 Cr (FY 2025)); and 7 more.
Rajiv Indravadan Modi was first appointed on 26 Mar 1990 as Director at Karnavati Engineering Private Limited. The most recent appointment on record is 20 Jul 2022 at Phd Chamber Of Commerce And Industry.
The 11 current companies of Rajiv Indravadan Modi that report revenue have a combined latest revenue of ₹5,694 Cr: Cadila Pharmaceuticals Limited ₹3,869 Cr (FY 2025); Irm Energy Limited ₹980 Cr (FY 2024); Apollo Hospitals International Limited ₹341 Cr (FY 2025); Irm Private Limited ₹307 Cr (FY 2025); Irm Enterprises Private Limited ₹152 Cr (FY 2025); and 6 more.
Rajiv Indravadan Modi held 17 earlier board appointments: Phd Chamber Of Commerce And Industry (Director, 20 Jul 2022 to 27 May 2024); Cadila Laboratories Private Limited (Director, 05 Oct 1991 to 08 Mar 2024); Stemcyte India Therapeutics Private Limited (Director, 13 Jun 2008 to 22 Feb 2022); Cpl Holdings Private Limited (Director, 01 Apr 2009 to 03 Dec 2017); Inverika Bioresearch Private Limited (Director, 07 Jun 2012 to 16 Mar 2022); and 12 more.
The current boards of Rajiv Indravadan Modi's companies include Girdhar Prem Balwani (Cadila Pharmaceuticals Limited), Kamlesh Navaratnalal Shah (Cadila Pharmaceuticals Limited), Parul Nikunj Shah (Cadila Pharmaceuticals Limited), Rajiv Rajiv Modi (Cadila Pharmaceuticals Limited), Ramesh Ratilal Choksi (Cadila Pharmaceuticals Limited), Renuka Anjanikumar Upadhyay (Cadila Pharmaceuticals Limited), among others.